Stocks making the biggest moves midday: Eli Lilly, 3M, PayPal, Tesla and more

Recessions And Depressions Nyheter

Stocks making the biggest moves midday: Eli Lilly, 3M, PayPal, Tesla and more
Currency Pegging,Central Banking,Monetary Policy

These were some of the stocks making the largest moves in trading on Tuesday.

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 34 min. at publisher
  • 📊 Quality Score:
  • News: 125%
  • Publisher: 72%

Check out the companies making headlines in midday trading. Eli Lilly — Shares added 5% after Eli Lilly, maker of the Mounjaro diabetes and weight loss drug, beat analysts' expectations for first-quarter adjusted earnings. The Indianapolis-based drugmaker also lifted its full-year guidance for adjusted earnings and revenue. 3M — Shares jumped 4% after the maker of industrial products and adhesives posted earnings of $2.39 per share on revenue of $7.

Current-quarter revenue is expected to come in higher than analysts anticipate. Amkor Technology — The semiconductor packaging company climbed nearly 7% after earnings and revenue topped analyst estimates. Earnings of 24 cents per share on $1.37 billion in revenue exceeded consensus forecasts of 11 cents and $1.36 billion, according to FactSet. Second quarter earnings and revenue guidance also topped expectations. Sysco — The wholesale restaurant supplier slipped 2.

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

CNBC /  🏆 12. in SE
 

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and moreStocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and moreThese are the stocks posting the largest moves in the premarket.
Läs mer »

Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysEli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Läs mer »



Render Time: 2025-01-12 02:07:58